In O’Connor v. Ford Motor Co., the United States District Court for the Northern District of Illinois addressed whether a Massachusetts Chapter 93A claim could proceed after the court had dismissed ...

Jharkhand Board Class 12 Biology Question Paper 2026 was conducted by the Jharkhand Academic Council (JAC) on 9 February 2026 (Evening Shift). The exam was held for a total of 70 marks with a writing ...

With a clutch of key data and planned regulatory applications this year from Avidity Biosciences, REGENXBIO and Capricor ...

CBSE Class 12 Biology last 10 days study plan for board exam 2026 with detailed day-wise revision strategy, daily timetable, high-weightage chapters, and exam-focused tips.

With the CBSE Board Exams 2026 fast approaching, it has become essential for students to understand what examiners actually look for in answer sheets. Using correct scientific terminology, following ...

A large global genetics study shows that many key drivers of Type 2 diabetes operate outside the bloodstream. Scientists are ...

Solved 2024-25 papers guide Class 12 students in answering techniques. Access CBSE Class 12 Biology topper answer sheets for the 2026 exam. CBSE Class 12 exams for 2026 board start Feb 17, 2025; check ...

Below are the Survivor perks for Eleven in Dead By Daylight, courtesy of BeHaviour’s update 9.4.0 patch notes: In addition to the perks for Eleven and Dustin, make sure to check out the perks for ...

Netflix is gearing up for the Dec. 16 return of hit reality cooking competition “Culinary Class Wars” with the release of its main trailer, as anticipation builds for the sophomore season of the ...

Light chain amyloidosis is not cancer, but cancer drugs are this rare disease’s standard of care. The patient need for new treatment options has sparked R&D efforts at biotech and big pharmaceutical ...

We finally have our first look at Warhammer 40,000: Space Marine 2’s new class, the Techmarine, as well as an image of its Omnissian Axe. Publisher Focus Entertainment released one screenshot of the ...

First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapies Topline safety, PK, and PD data anticipated in Q1 2026 Advances ongoing ...